Table: Kobayashi Pharmaceutical -Q1 group results
Apr 28 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2017 Mar 31, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 30.75 36.77 150.00
Operating 4.96 7.30 20.00
Recurring 4.85 7.14 21.00
Net 3.46 5.22 15.10
EPS 43.84 yen 64.97 yen 191.62 yen
EPS Diluted 43.81 yen 64.92 yen
Ann Div 52.00 yen 52.00 yen
-Q2 div 25.00 yen 26.00 yen
-Q4 div 27.00 yen 26.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows